Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Radial access in the U.S. is now approaching 50 percent. Tranradial access also shows benefit for mortality and decreases in acute kidney injury (AKI).
Feature | Radial Access | February 14, 2020 | Dave Fornell, Editor

Transradial access for percutaneous coronary intervention (PCI) in the United States has grown rapidly over the past...

A CSI Diamondabck 360 atheretectomy system in use during a cath lab procedure at Henry Ford Hospital in Detroit. Photo by Dave Fornell

A CSI Diamondabck 360 atheretectomy system in use during a cath lab procedure at Henry Ford Hospital in Detroit. Photo by Dave Fornell

News | Atherectomy Devices | February 13, 2020

February 13, 2020 — The U.S. Food and Drug Administration (FDA) has issued its final guidance on "Peripheral...

The DEFINE GPS (Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect: Guided Physiologic Stenting) study will be the first time that the use of iFR in conjunction with the Philips Image-Guided Co-registration System (SyncVision) is evaluated for PCI guidance and the optimization of treatment outcomes.

The DEFINE GPS study will be the first time that the use of iFR in conjunction with an angiography image-guided co-registration system for PCI guidance and the optimization.

News | Cath Lab Navigation Aids | February 12, 2020

February 12. 2020 — Philips announced a new randomized controlled trial to assess patient outcomes after receiving a...

he University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the first facility in the United States to install the Artis icono biplane angiography imaging system from Siemens Healthineers.
News | Angiography | February 12, 2020

February 12, 2020 — The University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became...

The Boston Scientific Eluvia self-expanding, drug-eluting, peripheral stent.

The Boston Scientific Eluvia self-expanding, drug-eluting, peripheral stent.

Feature | Stents | February 11, 2020 | Saloni Walimbe

Cardiovascular diseases (CVDs) are among the leading causes of death across the globe. For patients suffering from...

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 11, 2020

February 11, 2020 — An ahead-of-print...

The Aria CV Pulmonary Hypertension System (Aria CV PH System) received FDA Breakthrough Device status.
News | Hypertension | February 07, 2020

February 7, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the...

The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.20 annual meeting March 28-30, 2020, in Chicago. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.
Feature | ACC | March 27, 2020 | Dave Fornell, Editor

Here is the list of American College of Cardiology (ACC) practice...

New SIR position statement and quality documents highlight interventional radiology effective use of nonsurgical ablation to treat kidney cancer in selected patients
News | Interventional Radiology | February 04, 2020

February 4, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...

The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess Abbott's Amplatzer Amulet left atrial appendage (LAA) occluder for people with atrial fibrillation (AF or AFib). 
News | Left Atrial Appendage (LAA) Occluders | February 03, 2020

February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the...

Overlay Init